Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Hematology
•
Neurology
•
Vascular Neurology
•
Neurohospitalist
What is the preferred approach to managing non-occlusive or partially occlusive venous sinus thrombosis?
Answer from: at Academic Institution
I would recommend a DOAC, particularly apixaban, with follow-up imaging in 3 months.
Comments
at Northside Hospital
Thank you, Dr. @Kirshner. If it remains stable/unc...
at Vanderbilt University Medical Center
I think this is a question for which there is no r...
11705
11721
Sign In
or
Register
to read more
20808
Related Questions
Would you offer TPO-RAs to a steroid-refractory chronic ITP patient with history of stroke?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
How long would you continue chronic transfusion therapy for adult sickle cell patients who have had a stroke?
In a patient with cryptogenic stroke while on antecedent aspirin 81 mg, how do you decide between single antiplatelet therapy, dual antiplatelet therapy, or antiplatelet agent combined with anticoagulation such as rivaroxaban 2.5 mg BID?
How would you approach the upfront management of a patient with acute unilateral vision loss with strong clinical risk factors for both cardioembolic stroke and GCA if an expedited MRI is not possible due to the presence of an AICD?
How do you decide whether to place an NGT or PEG tube in patients with dysphagia precluding adequate PO nutritional intake?
Would you consider IV thrombolytics in patients with acute ischemic stroke, with or without a large vessel occlusion, if they have a history of von Willebrand disease (VWD), regardless of its type?
Under what circumstances do you recommend POCUS guidance for lumbar puncture?
How do you manage high-risk MDS IB2 patients on HMA and venetoclax who develop an acute stroke requiring antiplatelet therapy?
Do you prescribe GLP-1 agonists to diabetic patients admitted with minor CVA or TIA for secondary stroke prevention, as suggested by the LAMP trial?
Thank you, Dr. @Kirshner. If it remains stable/unc...
I think this is a question for which there is no r...